Anaptysbio (ANAB) Non-Current Assets (2016 - 2026)

Anaptysbio has reported Non-Current Assets for 11 years, with the latest figure at $13.6 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 76.97% year-over-year to $13.6 million; the trailing twelve-month figure through Mar 2026 stood at $93.5 million (down 56.64% YoY), and the FY2025 full-year result was $14.1 million, down 72.78% from the prior year.
• Non-Current Assets for Q1 2026 stood at $13.6 million, down from $14.1 million in the prior quarter.
• The five-year high for Non-Current Assets was $168.1 million in Q3 2022, with the low at $13.6 million in Q1 2026.
• Historically, Non-Current Assets has averaged $72.7 million across 5 years, with a median of $58.9 million in 2025.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 1114.17% — and 2026, when it tumbled 76.97%.
• Anaptysbio's Non-Current Assets stood at $163.2 million in 2022, then tumbled by 72.08% to $45.6 million in 2023, then advanced by 14.06% to $52.0 million in 2024, then tumbled by 72.78% to $14.1 million in 2025, then slipped by 4.03% to $13.6 million in 2026.
• The last three Non-Current Assets figures came in at $13.6 million (Q1 2026), $14.1 million (Q4 2025), and $22.4 million (Q3 2025), per Business Quant data.